NCT01431768 Validation of the Respirio Flu Test for the Rapid Identification of Influenza A/B Status COMPLETED Phase NA
NCT01430819 Study of Fluzone® Influenza Virus Vaccine 2011-2012 Formulation (Intramuscular Route) Among Adults Status COMPLETED Phase PHASE4
NCT01427309 A Study of Fluzone® High-Dose Vaccine Compared With Fluzone® Vaccine In Elderly Adults Status COMPLETED Phase PHASE4
NCT01424371 Adjuvanted Influenza Vaccine Effectiveness in the Elderly (65+Yrs) Status UNKNOWN Phase N/A
NCT01422512 Safety and Immunogenicity of One Dose of a Surface, Antigen, Inactivated, Influenza Vaccine Produced in Mammalian Cell Culture Administered to Adult and Elderly Subjects Status COMPLETED Phase PHASE3
NCT01419925 A Study to Assess the Safety and Immunogenicity of M-001 Influenza Vaccine as a Primer to TIV in Elderly Volunteers Status COMPLETED Phase PHASE2
NCT01416597 A Systematic Review of Studies of the Effect of Influenza Vaccine Against Mismatched Strains Status COMPLETED Phase N/A
NCT01416571 Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Monovalent Pandemic H5N1 Vaccine in Adults Status COMPLETED Phase PHASE2
NCT01412281 Immunogenicity and Safety Study to Assess Influenza Vaccine Formulated With Haemagglutinin (HA) Antigen From Two Different Suppliers Status COMPLETED Phase PHASE3
NCT01411358 Immunogenicity and Safety of AdimFlu-S 2011-2012 in Non-Elderly Adult and Elderly Subjects Status COMPLETED Phase NA
NCT01408290 Safety and Immunogenicity Study of Fluval AB-Like Flu Vaccines With 3.5, 6, 9 or 15 μg HA in Adult and Elderly People Status COMPLETED Phase NA
NCT01406418 Assessment of CR6261, a Monoclonal Antibody Against the Influenza A Virus Status COMPLETED Phase PHASE1
NCT01404182 Tolerability and Immunogenicity Study of Fluval AB Influenza Vaccine in Adults and Elderly Persons Status COMPLETED Phase PHASE4
NCT01389479 Study to Evaluate the Safety, Tolerance and Immunogenicity of Fluviral™ in Healthy Adults Status COMPLETED Phase PHASE3
NCT01389466 Study to Evaluate the Safety and Immunogenicity of MG1109 in Healthy Adult Volunteers Status COMPLETED Phase PHASE1/PHASE2
NCT01386424 Screening for LID Clinical Studies Unit Healthy Volunteer Protocols Status RECRUITING Phase N/A
NCT01379937 A Study to Evaluate the Safety and Immunogenicity of a Prime-boost Schedule of GSK Biologicals' Influenza Vaccine in Children Status COMPLETED Phase PHASE3
NCT01375985 Safety Study of Single Administration Intravenous Treatment for Influenza Status TERMINATED Phase PHASE1